Use of S1P receptor modulator

Details for Australian Patent Application No. 2008248648 (hide)

Owner Novartis AG

Inventors Deogracias, Ruben; Mir, Anis Khusro; Schubart, Anna Svenja; Kuhn, Rainer R.; Matsumoto, Tomoya; Bilbe, Graeme; Barde, Yves-Alain

Agent Davies Collison Cave

Pub. Number AU-B-2008248648

PCT Pub. Number WO2008/135522

Priority 60/915,985 04.05.07 US

Filing date 1 May 2008

Wipo publication date 13 November 2008

Acceptance publication date 23 February 2012

International Classifications

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

19 November 2009 PCT application entered the National Phase

  PCT publication WO2008/135522 Priority application(s): WO2008/135522

23 February 2012 Application Accepted

  Published as AU-B-2008248648

21 June 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008248649-Method and device for cleaning an absorptive polyester

2008248640-Vaccine